PLCββ1-SHP-2 complex, PLCββ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: A new part of Angiotensin II signaling?

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Calò, Lorenzo A ^a   Bordin, Luciana ^a   Davis, Paul A ^b   Pagnin, Elisa ^a   Dal Maso, Lucia ^a   Rossi, Gian Paolo ^a   Pessina, Achille C ^a   Clari, Giulio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin II signaling; PLC 1; SHP 2; SHP 2 PLC 1 complex

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; GUANINE NUCLEOTIDE BINDING PROTEIN; LOSARTAN; PHOSPHATIDYLINOSITOL SPECIFIC PHOSPHOLIPASE C BETA 1; PHOSPHODIESTERASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG; PHOSPHOLIPASE C BETA; RGS PROTEIN; TYROSINE; VANADIC ACID;

ARTICLE; CELL CULTURE; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; METABOLISM; PHOSPHORYLATION;

ANGIOTENSIN II; BLOTTING, WESTERN; CELLS, CULTURED; FIBROBLASTS; HUMANS; PHOSPHOLIPASE C BETA; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RECEPTOR, ANGIOTENSIN, TYPE 1; RGS PROTEINS; SIGNAL TRANSDUCTION; TYROSINE; VANADATES;

EID: 79958285227     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-38     Document Type: Article

References (30)

1. Angiotensin II Cell Signaling. Physiological and Pathological Effects in the Cardiovascular System. PK Mehta KK Griendling, Am J Physiol Cell Physiol 2007 92 82 C97 (Pubitemid 46127306)
2. Inositol trisphosphate and calcium signalling. MJ Berridge, Nature 1993 361 315 25 10.1038/361315a0 8381210 (Pubitemid 23041621)
3. Signaling mechanisms underlying the vascular myogenic response. MJ Davis MH Hill, Physiol Rev 1999 70 387 423 (Pubitemid 29210926)
4. Role of angiotensin II in regulating vascular structural and functional changes in hypertension. RM Touyz, Curr Hypertens Rep 2003 5 155 64 10.1007/s11906-003-0073-2 12642016 (Pubitemid 38898946)
5. Temporal dispersion of activation of phospholipase C-beta1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq/11, alpha12, and beta gamma G protein subunits. M Ushio-Fukai KK Griendling M Akers PR Lyons RW Alexander, J Biol Chem 1998 273 19772 7 10.1074/jbc.273.31.19772 9677408 (Pubitemid 28367037)
6. Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR. F Tabet EL Schiffrin GE Callera Y He G Yao A Ostman K Kappert NK Tonks RM Touyz, Circ Res 2008 103 149 58 10.1161/CIRCRESAHA.108.178608 18566342
7. Angiotensin II Stimulates Tyrosine Phosphorylation and Activation of Insulin Receptor Substrate 1 and Protein-tyrosine Phosphatase1D in Vascular Smooth Muscle Cells. MS Ali B Schieffer P Delafontaine KE Bernstein BN Ling MB Marrero, J Biol Chem 1997 272 12373 9 10.1074/jbc.272.19.12373 9139682 (Pubitemid 27203323)
8. Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance. H Maegawa M Hasegawa S Sugai T Obata S Ugi K Morino K Egawa T Fujita T Sakamoto Y Nishio H Kojima M Haneda H Yasuda R Kikkawa A Kashiwagi, J Biol Chem 1999 274 30236 43 10.1074/jbc.274.42.30236 10514516
9. Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells. T Doan P Farmer T Cooney MS Ali, Cell Signal 2004 16 301 11 10.1016/j.cellsig.2003.08.001 14687660 (Pubitemid 37542405)
10. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. LD Klaman B Chen T Araki H Harada SM Thomas EL George BG Neel, Dev Cell 2006 10 317 27 10.1016/j.devcel.2006.01.002 16516835
11. Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. J Bregeon G Loirand P Pacaud M Rolli-Derkinderen, Am J Physiol Cell Physiol 2009 297 1062 70 10.1152/ajpcell.00174.2009 19692654
12. Rho kinases in cardiovascular physiology and pathophysiology. G Loirand P Guerin P Pacaud, Circ Res 2006 98 322 34 10.1161/01.RES.0000201960.04223.3c 16484628
13. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans. LA Cal AC Pessina, J Hypertens 2007 25 259 64 10.1097/HJH.0b013e328010d4d2 17211228 (Pubitemid 46071919)
14. Galphaq binds two effectors separately in cells: evidence for predetermined signaling pathways. U Golebiewska S Scarlata, Biophys J 2008 95 2575 82 10.1529/biophysj.108.129353 18515384
15. Vascular tone control in humans: the utility of studies in Bartter's/Gitelman's syndromes. LA Cal Kidney Int 2006 69 963 6 10.1038/sj.ki.5000253 16528244
16. Angiotensin II signaling in the Bartter's and Gitelman's syndromes, a negative human model of hypertension. LA Cal AC Pessina A Semplicini, High Blood Press Cardiovasc Prev 2005 12 17 26 10.2165/00151642-200512010-00004 (Pubitemid 41032054)
17. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways. LA Cal M Puato S Schiavo M Zanardo C Tirrito E Pagnin G Balbi PA Davis P Palatini P Pauletto, Nephrol Dial Transplant 2008 23 2804 9 10.1093/ndt/gfn118 18344243
18. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved? LA Cal R Montisci R Scognamiglio PA Davis E Pagnin S Schiavo P Mormino A Semplicini P Palatini A D'Angelo AC Pessina, J Endocrinol Invest 2009 32 832 6 19605975
19. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. LA Cal S Schiavo PA Davis E Pagnin P Mormino A D'Angelo AC Pessina, J Hypertens 2010 28 111 8 10.1097/HJH.0b013e328332b738 19797979
20. Regulators of G protein signaling: a spotlight on emerging functions in the cardiovascular system. T Wieland S Lutz P Chidiac, Curr Opin Pharmacol 2007 7 1 7 10.1016/j.coph.2006.12.002 (Pubitemid 46238046)
21. RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. S Gu C Cifelli S Wang SP Heximer, Clin Sci 2009 116 391 9 10.1042/CS20080272 19175357
22. SHP-2 tyrosine phosphatase in human diseases. H Zheng S Alter CK Qu, Int J Clin Exp Med 2009 2 17 25 19436828
23. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. BG Neel H Gu L Pao, Trends Biochem Sci 2003 28 284 93 10.1016/S0968-0004(03)00091-4 12826400 (Pubitemid 36776291)
24. Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response. CK Qu, Biochim Biophys Acta 2002 1592 297 301 10.1016/S0167-4889(02)00322-1 12421673
25. SHP-2 modulates interleukin-1-induced Ca2+ flux and ERK activation via phosphorylation of phospholipase Cgamma1. Q Wang GP Downey MT Herrera-Abreu A Kapus CA McCulloch, J Biol Chem 2005 280 8397 406 15563458 (Pubitemid 40349744)
26. Gq-initiated cardiomyocyte hypertrophy is mediated by phospholipase Cbeta1b. TM Filtz DR Grubb TJ McLeod-Dryden J Luo EA Woodcock, FASEB J 2009 23 3564 70 10.1096/fj.09-133983 19564249
27. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes. LA Cal E Pagnin G Ceolotto PA Davis S Schiavo I Papparella A Semplicini AC Pessina, J Hypertens 2008 26 938 45 10.1097/HJH.0b013e3282f60d98 18398336 (Pubitemid 351520981)
28. Reduced expression of regulator of G protein signaling-2 in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. A Semplicini L Lenzini M Sartori I Papparella LA Cal E Pagnin G Strapazzon C Benna R Costa A Avogaro G Ceolotto AC Pessina, J Hypertens 2006 24 1115 24 10.1097/01.hjh.0000226202.80689.8f 16685212 (Pubitemid 43772320)
29. Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes. L Calo G Ceolotto M Milani E Pagnin LP van den Heuvel M Sartori PA Davis R Costa A Semplicini, Kidney Int 2001 60 882 9 10.1046/j.1523-1755.2001. 060003882.x 11532083 (Pubitemid 34205788)
30. Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling. E Pagnin PA Davis M Sartori A Semplicini AC Pessina LA Calo, J Hypertens 2004 22 1963 9 10.1097/00004872-200410000-00019 15361768 (Pubitemid 39336679)